SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities
SEC Accession No. 0001209191-12-016316
Filing Date
2012-03-07
Accepted
2012-03-07 09:01:44
Documents
1
Period of Report
2012-03-06
Filing Date Changed
2012-03-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5280
  Complete submission text file 0001209191-12-016316.txt   6849
Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Issuer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 11388 SORRENTO VALLEY RD STE 200 SAN DIEGO CA 92121
Business Address
MATHEWS CHARLES (Reporting) CIK: 0001190315 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15803 | Film No.: 12672596